As global drug giants grow cautious, can Chinese biotech keep cashing in on out-licensing?
AdvertisementBiomedicine: Industry TrendsBusinessChina Business As global drug giants grow cautious, can Chinese biotech keep cashing in on out-licensing? 3-MIN READ3-MIN…